CLINICAL IMPACT OF DOSE MODIFICATION AND DOSE INTENSITY ON RESPONSE TO PONATINIB IN PATIENTS (PTS) WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH plus ) LEUKEMIAS

被引：0

作者：

Nicolini, F. E. ^{[1
]}

Cortes, J. E. ^{[2
]}

Kim, D. W. ^{[3
]}

Pinilla-Ibarz, J. ^{[4
]}

le Coutre, P. D. ^{[5
]}

Paquette, R. ^{[6
]}

Chuah, C. ^{[7
]}

Apperley, J. F. ^{[8
]}

Khoury, H. J. ^{[9
]}

Talpaz, M. ^{[10
]}

DiPersio, J. F. ^{[11
]}

DeAngelo, D. J. ^{[12
]}

Abruzzese, E. ^{[13
]}

Rea, D. ^{[14
,15
]}

Baccarani, M. ^{[16
]}

Muller, M. C. ^{[17
]}

Gambacorti-Passerini, C. ^{[18
]}

Lustgarten, S. ^{[19
]}

Rivera, V. M. ^{[19
]}

Haluska, F. G. ^{[19
]}

Guilhot, F. ^{[20
]}

Deininger, M. W. ^{[21
]}

Hughes, T. P. ^{[22
]}

Shah, N. P. ^{[23
]}

Kantarjian, H. M. ^{[2
]}

Hochhaus, A. ^{[24
]}

机构：

[1] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea

[4] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA

[5] Charite, D-13353 Berlin, Germany

[6] Univ Calif Los Angeles, Ronald Reagan UCLA Med Ctr, Los Angeles, CA USA

[7] Singapore Gen Hosp, Duke NUS Grad Med Sch, Singapore, Singapore

[8] Univ London Imperial Coll Sci Technol & Med, London, England

[9] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[10] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[11] Washington Univ, Sch Med, St Louis, MO USA

[12] Dana Farber Canc Inst, Boston, MA 02115 USA

[13] Univ Roma Tor Vergata, S Eugenio Hosp, Rome, Italy

[14] Hop St Louis, Serv Malad Sang, Paris, France

[15] Hop St Louis, CIC Clin Invest Ctr, Paris, France

[16] S Orsola Malpighi Univ Hosp, Bologna, Italy

[17] Univ Med, Med Klin 3, Mannheim, Germany

[18] Azienda Osped San Gerardo Univ Milano Bicocca, Unita Ric Clin Ematol, Monza, Italy

[19] ARIAD Pharmaceut Inc, Cambridge, MA USA

[20] Univ Hosp, CHU Poitiers, Poitiers, France

[21] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[22] Inst Med & Vet Sci, Adelaide, SA 5000, Australia

[23] Univ Calif San Francisco, San Francisco, CA 94143 USA

[24] Univ Klinikum Jena, Jena, Germany

来源：

HAEMATOLOGICA | 2014年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P894

引用

页码：334 / 334

页数：1

共 50 条

[1] Clinical impact of dose modification and dose intensity on response to ponatinib (PON) in patients (pts) with Philadelphia chromosome-positive (Ph plus ) leukemias.
Hochhaus, Andreas
Pinilla-Ibarz, Javier
Kim, Dong-Wook
Le Coutre, Philipp D.
Paquette, Ronald
Chuah, Charles
Nicolini, Franck E.
Apperley, Jane
Khoury, Hanna Jean
Baccarani, Michele
Lustgarten, Stephanie
Rivera, Victor M.
Haluska, Frank G.
Guilhot, Francois
Deininger, Michael W. N.
Hughes, Timothy P.
Shah, Neil P.
Kantarjian, Hagop M.
Talpaz, Moshe
Cortes, Jorge E.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[2] IMPACT OF BASELINE MUTATIONS ON RESPONSE TO PONATINIB AND END OF TREATMENT MUTATION ANALYSIS IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ( PH plus ) LEUKEMIAS
Hughes, T.
Cortese, J.
Kim, D.
Nicolini, F.
Talpaz, M.
Baccarani, M.
Mueller, M.
Lustgarten, S.
Rivera, V.
Clackson, T.
Turner, C.
Haluska, F.
Guilhot, F.
Hochhaus, A.
Goldman, J.
Shah, N.
Kantarjian, H.
Deininger, M.
HAEMATOLOGICA, 2013, 98 : 57 - 57
[3] Ponatinib in Philadelphia Chromosome-Positive Leukemias Reply
Cortes, Jorge E.
Talpaz, Moshe
Kantarjian, Hagop
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (06) : 577 - 577
[4] Ponatinib in Refractory Philadelphia Chromosome-Positive Leukemias
Cortes, Jorge E.
Kantarjian, Hagop
Shah, Neil P.
Bixby, Dale
Mauro, Michael J.
Flinn, Ian
O'Hare, Thomas
Hu, Simin
Narasimhan, Narayana I.
Rivera, Victor M.
Clackson, Tim
Turner, Christopher D.
Haluska, Frank G.
Druker, Brian J.
Deininger, Michael W. N.
Talpaz, Moshe
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (22) : 2075 - 2088
[5] Longer-term follow up of a phase I study of ponatinib in patients (pts) with Philadelphia chromosome-positive (Ph plus ) leukemias.
Talpaz, Moshe
Cortes, Jorge E.
Kantarjian, Hagop M.
Shah, Neil P.
Bixby, Dale L.
Flinn, Ian
O'Hare, Thomas
Hu, Simin
Rivera, Victor M.
Clackson, Tim
Turner, Christopher D.
Haluska, Frank G.
Drucker, Brian J.
Deininger, Michael W. N.
Mauro, Michael J.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[6] LONGER-TERM FOLLOW-UP OF A PHASE 1 STUDY OF PONATINIB IN PATIENTS (PTS) WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH plus ) LEUKEMIAS
Cortes, J.
Talpaz, M.
Kantarjian, H. M.
Shah, N. P.
Bixby, D.
Flinn, I. W.
O'Hare, T.
Hu, S.
Rivera, V.
Clackson, T.
Turner, C.
Haluska, F.
Druker, B. J.
Deininger, M. W.
Mauro, M. J.
HAEMATOLOGICA, 2014, 99 : 335 - 335
[7] A Phase 2 Trial of Ponatinib in Philadelphia Chromosome-Positive Leukemias
Cortes, J. E.
Kim, D. -W.
Pinilla-Ibarz, J.
le Coutre, P.
Paquette, R.
Chuah, C.
Nicolini, F. E.
Apperley, J. F.
Khoury, H. J.
Talpaz, M.
DiPersio, J.
DeAngelo, D. J.
Abruzzese, E.
Rea, D.
Baccarani, M.
Mueller, M. C.
Gambacorti-Passerini, C.
Wong, S.
Lustgarten, S.
Rivera, V. M.
Clackson, T.
Turner, C. D.
Haluska, F. G.
Guilhot, F.
Deininger, M. W.
Hochhaus, A.
Hughes, T.
Goldman, J. M.
Shah, N. P.
Kantarjian, H.
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (19) : 1783 - 1796
[8] Efficacy and safety following bosutinib dose reduction in patients with Philadelphia chromosome-positive leukemias
Kota, Vamsi
Bruemmendorf, Tim H.
Gambacorti-Passerini, Carlo
Lipton, Jeff H.
Kim, Dong-Wook
An, Fiona
Leip, Eric
Crescenzo, Rocco J.
Ferdinand, Roxanne
Cortes, Jorge E.
LEUKEMIA RESEARCH, 2021, 111
[9] Further Analytical, Pharmacokinetic, and Clinical Observations on Low-Dose Ponatinib in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Menna, Pierantonio
De Grazia, Ugo
Marchesi, Francesco
Minotti, Giorgio
Salvatorelli, Emanuela
CHEMOTHERAPY, 2020, 65 (1-2) : 35 - 41
[10] Ponatinib vs Imatinib with Reduced-Intensity Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive (Ph plus ) ALL: PhALLCON Study
Jabbour, Elias
Martinelli, Giovanni
Vignetti, Marco
Ribera, Jose-Maria
Gomez-Almaguer, David
Minami, Yosuke
Xu, Jing
Srivastava, Shouryadeep
Neumann, Frank
Kantarjian, Hagop
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S194 - S194

← 1 2 3 4 5 →